Source:http://linkedlifedata.com/resource/pubmed/id/20109105
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-5-13
|
pubmed:abstractText |
Wnt/beta-catenin/T cell factor (TCF) pathway is activated in several types of human cancers, promoting cell growth and proliferation. Forkhead box containing protein class O (FOXO) transcription factors compete with TCF for beta-catenin binding, particularly under cellular oxidative stress conditions. Contrary to beta-catenin/TCF, beta-catenin/FOXO promotes the transcription of genes involved in cell cycle arrest and apoptosis. We have previously demonstrated that in vivo interferon-alpha2b (IFN-alpha2b) administration induces apoptosis in preneoplastic livers, a mechanism mediated by reactive oxygen species (ROS) and transforming growth factor-beta(1) (TGF-beta(1)). This study was aimed to assess the status of the Wnt/beta-catenin/TCF pathway in a very early stage of rat hepatocarcinogenesis and to further evaluate the effects of in vivo IFN-alpha2b treatment on it. We demonstrated that the Wnt/beta-catenin/TCF pathway is activated in preneoplastic rat livers. More important, in vivo IFN-alpha2b treatment inhibits Wnt/beta-catenin/TCF pathway and promotes programed cell death possibly providing a link with FOXO pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TCF Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Wnt Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1029-2292
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
166-77
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20109105-Animals,
pubmed-meshheading:20109105-Apoptosis,
pubmed-meshheading:20109105-Humans,
pubmed-meshheading:20109105-Interferon-alpha,
pubmed-meshheading:20109105-Liver Neoplasms, Experimental,
pubmed-meshheading:20109105-Male,
pubmed-meshheading:20109105-Precancerous Conditions,
pubmed-meshheading:20109105-Rats,
pubmed-meshheading:20109105-Rats, Wistar,
pubmed-meshheading:20109105-Recombinant Proteins,
pubmed-meshheading:20109105-TCF Transcription Factors,
pubmed-meshheading:20109105-Wnt Proteins,
pubmed-meshheading:20109105-beta Catenin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Attenuation of the Wnt/beta-catenin/TCF pathway by in vivo interferon-alpha2b (IFN-alpha2b) treatment in preneoplastic rat livers.
|
pubmed:affiliation |
Instituto de Fisiología Experimental, Consejo Nacional de Investigaciones Científicas y T écnicas (CONICET), 2000 Rosario, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|